Related Experiment Video
Updated: Aug 20, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA
Nadia Abdel Wahab1, Benjamin S Weston, Roger M Mason
1Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 ONN, UK. nadia.wahab@imperial.ac.uk
Abstract:
Connective tissue growth factor (CTGF) is implicated as a factor promoting tissue fibrosis in several disorders, including diabetic nephropathy. However, the molecular mechanism(s) by which it functions is not known. CTGF rapidly activates several intracellular signaling molecules in human mesangial cells (HMC), including extracellular signal-related kinase 1/2, Jun NH(2)-terminal kinase, protein kinase B, CaMK II, protein kinase Calpha, and protein kinase Cdelta, suggesting that it functions via a signaling receptor. Treating HMC with CTGF stimulated tyrosine phosphorylation of proteins 75 to 80 and 140 to 180 kD within 10 min, and Western blot analysis of anti-phosphotyrosine immunoprecipitates identified the neurotrophin receptor TrkA (molecular weight approximately 140 kD). Cross-linking rCTGF to cell surface proteins with 3,3'-dithiobis(sulfosuccinimidylpropionate) revealed that complexes formed with TrkA and with the general neurotrophin co-receptor p75(NTR). rCTGF stimulated phosphorylation of TrkA (tyr 490, 674/675). K252a, a known selective inhibitor of Trk, blocked this phosphorylation, CTGF-induced activation of signaling proteins, and CTGF-dependent induction of the transcription factor TGF-beta-inducible early gene in HMC. It is concluded that TrkA serves as a tyrosine kinase receptor for CTGF.
Insights
Connective tissue growth factor (CTGF) promotes fibrosis by activating intracellular signaling. Researchers found that CTGF uses the TrkA receptor tyrosine kinase to mediate these effects in human mesangial cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Nephrology
Background:
- Connective tissue growth factor (CTGF) is linked to tissue fibrosis in conditions like diabetic nephropathy.
- The precise molecular mechanisms underlying CTGF's role in fibrosis remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of Connective tissue growth factor (CTGF) signaling in human mesangial cells (HMC).
- To identify the receptor mediating CTGF's intracellular effects.
Main Methods:
- Human mesangial cells (HMC) were treated with CTGF.
- Tyrosine phosphorylation was analyzed via Western blot and immunoprecipitation.
- Receptor-ligand interactions were studied using cross-linking.
- Inhibitor studies with K252a were performed to assess pathway involvement.
Main Results:
- CTGF rapidly activated multiple intracellular signaling molecules (ERK1/2, JNK, Akt, CaMK II, PKCα/δ) in HMC.
- Tyrosine phosphorylation of specific proteins, including the neurotrophin receptor TrkA, was observed.
- CTGF formed complexes with TrkA and p75(NTR) on the cell surface.
- CTGF-induced TrkA phosphorylation and downstream signaling were blocked by the Trk inhibitor K252a.
Conclusions:
- TrkA functions as a tyrosine kinase receptor for Connective tissue growth factor (CTGF).
- This TrkA-mediated signaling pathway is crucial for CTGF-induced cellular responses, including the induction of TGF-beta-inducible early gene.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases
Intracellular Signaling Affects Focal Adhesions
Some...
TGF - β Signaling Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
